Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C

Author： Takaki Shintaro   Tsubota Akihito   Hosaka Tetsuya   Akuta Norio   Someya Takashi   Kobayashi Masahiro   Suzuki Fumitaka   Suzuki Yoshiyuki   Saitoh Satoshi   Arase Yasuji   Ikeda Kenji   Kumada Hiromitsu  

Publisher： Springer Publishing Company

ISSN： 0944-1174

Source： Journal of Gastroenterology, Vol.39, Iss.7, 2004-07, pp. : 668-673

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C

By Arase Yasuji   Ikeda Kenji   Suzuki Fumitaka   Suzuki Yoshiyuki   Saitoh Satoshi   Kobayashi Masahiro   Akuta Norio   Someya Takashi   Hosaka Tetsuya   Sezaki Hitomi   Kobayashi Mariko   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 39, Iss. 11, 2004-11 ,pp. : 1090-1094

Springer Publishing Company

Access to resources Recommend Favorite

Response to Combination Therapy with Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C According to a TNF-α Promoter Polymorphism

By  

Digestion, Vol. 68, Iss. 1, 2003-10 ,pp. : 1-4

Karger

Access to resources Recommend Favorite

Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C

By Oze Tsugiko   Hiramatsu Naoki   Kurashige Nao   Tsuda Natsuko   Yakushijin Takayuki   Kanto Tatsuya   Takehara Tetsuo   Kasahara Akinori   Kato Michio   Yoshihara Harumasa   Katayama Kazuhiro   Kubota Shinji   Hijioka Taizo   Ishibashi Kazunobu   Oshita Masahide   Hagiwara Hideki   Haruna Yoshimichi   Mita Eiji   Tamura Shinji   Hayashi Norio  

Journal of Gastroenterology, Vol. 41, Iss. 9, 2006-09 ,pp. : 862-872

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of Interferon Alfa-2b With and Without Ribavirin as Therapy for Chronic Hepatitis C in Sweden

By Sennfält K.   Reichard O.   Hultkrantz R.   Wong J. B.   Jonsson D.  

Scandinavian Journal of Gastroenterology, Vol. 36, Iss. 8, 2001-08 ,pp. : 870-876

Informa Healthcare

Access to resources Recommend Favorite

Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C

By Tohra S.  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2449-2455

Springer Publishing Company

Access to resources Recommend Favorite